Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LENALIDOMIDE, with a corresponding US DMF Number 27116.
Remarkably, this DMF maintains an Active status since its submission on June 04, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2016, and payment made on April 13, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II